| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,040,000 |
| Market
Cap: |
957.95(M) |
| Last
Volume: |
52,521 |
Avg
Vol: |
94,924 |
| 52
Week Range: |
$41.52 - $67.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ INDUSTRIAL |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile USANA Health Sciences develops and manufactures science-based nutritional, personal care and skincare products. Co.'s principal product lines include: USANA® Nutritionals Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs; Essentials/CellSentials®, which includes primary vitamin and mineral supplements that provide a foundation of body nutrition for every age group with children 13 months of age; Foods, which includes meal replacement shakes, snack bars, and other related products that provide macro-nutrition in various formats; and Personal Care and Skincare, which includes its science-based personal care products and Celavive.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,591 |
67,531 |
80,635 |
161,142 |
| Total Sell Value |
$1,458,123 |
$3,189,778 |
$4,028,724 |
$9,145,911 |
| Total People Sold |
5 |
13 |
15 |
17 |
| Total Sell Transactions |
7 |
17 |
27 |
52 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Macuga Daniel A. |
Chief Communications Officer |
• – – |
2018-09-04 |
4 |
S |
$130.09 |
$318,968 |
D/D |
(2,452) |
0 |
|
- |
|
| Macuga Daniel A. |
Chief Communications Officer |
• – – |
2018-09-04 |
4 |
OE |
$70.75 |
$173,467 |
D/D |
2,452 |
2,452 |
|
- |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2018-09-04 |
4 |
S |
$130.08 |
$305,421 |
D/D |
(2,348) |
0 |
|
- |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2018-09-04 |
4 |
OE |
$70.75 |
$166,109 |
D/D |
2,348 |
2,348 |
|
- |
|
| Wentz Myron W |
Director |
– • – |
2018-08-21 |
4 |
S |
$131.35 |
$7,881,000 |
I/I |
(60,000) |
10,055,614 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-08-21 |
4 |
S |
$131.35 |
$7,881,000 |
D/D |
(60,000) |
10,055,614 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2018-08-17 |
4 |
S |
$128.73 |
$969,310 |
D/D |
(7,530) |
0 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2018-08-17 |
4 |
OE |
$65.48 |
$493,064 |
D/D |
7,530 |
7,530 |
|
- |
|
| Auciaux Robert |
Director |
– • – |
2018-08-17 |
4 |
A |
$115.30 |
$9,801 |
D/D |
85 |
197 |
|
- |
|
| Auciaux Robert |
Director |
– • – |
2018-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
282 |
282 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2018-08-16 |
4 |
S |
$129.39 |
$932,999 |
D/D |
(7,211) |
0 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2018-08-16 |
4 |
OE |
$65.48 |
$472,176 |
D/D |
7,211 |
7,211 |
|
- |
|
| Wentz Myron W |
Director |
– • – |
2018-08-09 |
4 |
S |
$131.00 |
$5,240,000 |
I/I |
(40,000) |
10,115,614 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-08-09 |
4 |
S |
$131.00 |
$5,240,000 |
D/D |
(40,000) |
10,115,614 |
|
- |
|
| Wentz Myron W |
Director |
– • – |
2018-08-08 |
4 |
S |
$131.05 |
$6,552,500 |
I/I |
(50,000) |
10,155,614 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-08-08 |
4 |
S |
$131.05 |
$6,552,500 |
D/D |
(50,000) |
10,155,614 |
|
- |
|
| Wentz Myron W |
Director |
– • – |
2018-08-06 |
4 |
S |
$131.00 |
$13,100,000 |
I/I |
(100,000) |
10,205,614 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-08-06 |
4 |
S |
$131.00 |
$13,100,000 |
D/D |
(100,000) |
10,205,614 |
|
- |
|
| Wentz Myron W |
Director |
– • – |
2018-08-03 |
4 |
S |
$131.60 |
$6,580,000 |
I/I |
(50,000) |
10,305,614 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-08-03 |
4 |
S |
$131.60 |
$6,580,000 |
D/D |
(50,000) |
10,305,614 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-08-02 |
4 |
AS |
$127.68 |
$1,899,260 |
D/D |
(14,638) |
10,355,614 |
|
- |
|
| Wentz Myron W |
Director |
– • – |
2018-08-02 |
4 |
AS |
$127.68 |
$1,899,260 |
I/I |
(14,638) |
10,355,614 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-08-01 |
4 |
AS |
$127.24 |
$3,247,899 |
D/D |
(25,362) |
10,370,252 |
|
- |
|
| Wentz Myron W |
Director |
– • – |
2018-08-01 |
4 |
AS |
$127.24 |
$3,247,899 |
I/I |
(25,362) |
10,370,252 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2018-07-31 |
4 |
AS |
$131.50 |
$13,150,000 |
D/D |
(100,000) |
10,395,614 |
|
- |
|
1328 Records found
|
|
Page 36 of 54 |
|
|
0.54 (1.2%) 
